1 Min Read
Jan 12 (Reuters) - Isr Immune System Regulation Holding Ab (Publ):
* SWEDISH REGULATOR APPROVES Q1 LAUNCH OF PHASE IIA STUDY Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.